Kanada - İngilizce - Health Canada

air liquide canada inc. - carbon dioxide - gas - 100% - carbon dioxide 100% - other miscellaneous therapeutic agents

Kanada - İngilizce - Health Canada

linde canada inc. - carbon dioxide - gas - 99% - carbon dioxide 99% - other miscellaneous therapeutic agents

Kanada - İngilizce - Health Canada

messer canada inc. - carbon dioxide - gas - 99% - carbon dioxide 99% - other miscellaneous therapeutic agents

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

linde sverige ab - carbon 0,28 %; helium 9,3 % - medicinal gas, compressed - carbon monoxide 0.28 %; helium 9.3 % - other diagnostic agents

Singapur - İngilizce - HSA (Health Sciences Authority)

tebonin - tablets

ABD - İngilizce - NLM (National Library of Medicine)

genentech, inc. - ibandronate sodium (unii: j12u072ql0) (ibandronic acid - unii:umd7g2653w) - ibandronic acid 150 mg - boniva is indicated for the treatment and prevention of osteoporosis in postmenopausal women. boniva increases bone mineral density (bmd) and reduces the incidence of vertebral fractures. the optimal duration of use has not been determined. the safety and effectiveness of boniva for the treatment of osteoporosis are based on clinical data of three years duration. all patients on bisphosphonate therapy should have the need for continued therapy re-evaluated on a periodic basis. patients at low-risk for fracture should be considered for drug discontinuation after 3 to 5 years of use. patients who discontinue therapy should have their risk for fracture re-evaluated periodically. boniva is contraindicated in patients with the following conditions: - abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia (see warnings and precautions [5.1]) - inability to stand or sit upright for at least 60 minutes (see dosage and administration [2.2], and warnings and precautions [5.1]) - h

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sodium bicarbonate, quantity: 8.4 g - injection, intravenous infusion - excipient ingredients: disodium edetate; water for injections - 1. metabolic acidosis in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis where a rapid increase in plasma total co2 content is crucial. treatment of metabolic acidosis should be concurrent with measures designed to control the cause of the acidosis. 2.urinary alkalinisation in the treatment of certain drug intoxications (ie barbiturates, salicylates, lithium, methyl alcohol) and in the haemolytic reactions requiring alkalinisation of the urine to diminish nephrotoxicity of blood pigments. urinary alkalinisation is also used in methotrexate therapy to prevent nephrotoxicity. 3.severe diarrhoea which is often accompanied by a significant loss of bicarbonate.

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - naphthalene; eucalyptus oil; chlorfenvinphos; cresylic acid; liquid hydrocarbon - topical aerosol spray - naphthalene ungrouped active 60.0 g/l; eucalyptus oil oil-plant extract active 25.0 g/l; chlorfenvinphos organophosphorus active 2.5 g/l; cresylic acid phenol active 25.0 g/l; liquid hydrocarbon solvent other 776.0 g/l - parasiticides - cattle | horse | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | colt | cow | dairy cow | d - fly strike | marking wound | mules wound | superficial wounds | blowfly strike | body & crutch strike | body strike only | control infection | crutch strike | mulesing | poll strike

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - sodium bicarbonate 8.4%;  ;   - solution for injection - 8.4 % - active: sodium bicarbonate 8.4%     excipient: disodium edetate sodium hydroxide - sodium bicarbonate is used as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates) to decrease renal absorption of the drug or to correct acidosis.

İsrail - İngilizce - Ministry of Health

rekah pharmaceutical industry ltd, israel - sodium bicarbonate - tablets - sodium bicarbonate 500 mg - sodium bicarbonate - sodium bicarbonate - antacid.